Home LiteratureArticle Details
PMID: 9600229 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.

Journal of neuropathology and experimental neurology ·Vol. 57 ·No. 4 ·1998-04-00 ·Pages 353-9

Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM

Abstract

Cerebrovascular deposits of amyloid (cerebral amyloid angiopathy, or CAA) are generally asymptomatic, but in advanced cases, they can lead to vessel rupture and hemorrhage. The process of progression in CAA was studied by comparison of postmortem brains with asymptomatic ("mild") CAA to brains with the form of the disease associated with hemorrhage ("severe CAA"). Cortical and meningeal vessels were immunostained for beta-amyloid and examined by confocal microscopy and by systematic quantitative sampling. We focused on 2 quantitative parameters: the proportion of vessels affected by amyloid (a measure of amyloid seeding of vessels) and the amount of amyloid per affected vessel (a measure of growth of existing lesions). Surprisingly, there was no difference between the proportion of affected cortical vessels in mild and severe CAA (0.29 vs 0.32, p = 0.65), but rather an increase in the area of the 40 amino acid form of beta-amyloid per affected cortical vessel (198.5 +/- 38.7 vs 455.8 +/- 100.9 microm2/vessel, p < 0.007). Increasing doses (from 0 to 1 to 2 copies) of the apolipoprotein E epsilon4 allele were also associated with greater amyloid per vessel without change in the proportion of affected vessels within each class of CAA severity. These findings suggest that progression from asymptomatic to advanced CAA reflects progressive accumulation of amyloid in vessels previously seeded with amyloid, and that this process is selectively enhanced by apolipoprotein E epsilon4.

MeSH Terms
Aging Amyloid beta-Peptides/metabolism Apolipoproteins E/genetics Blood Vessels/metabolism,pathology Cerebral Amyloid Angiopathy/metabolism,pathology Cerebral Cortex/blood supply,pathology Disease Progression Fluorescent Antibody Technique, Indirect Humans Meninges/blood supply,pathology Microscopy, Confocal Peptide Fragments/metabolism Polymerase Chain Reaction
Chemicals
Amyloid beta-Peptides Apolipoproteins E Peptide Fragments amyloid beta-protein (1-40)
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Alonzo N C
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Hyman B T
Rebeck G W
Greenberg S M
Article Info
Journal
Journal of neuropathology and experimental neurology
Abbr.
J Neuropathol Exp Neurol
ISSN
0022-3069
Published
1998-04-00
Pages
353-9
Language
English
Region
England
NLM ID
2985192R
Subset
IM
Grants
NIA NIH HHS · AG00725 · United States
NIA NIH HHS · AG12406 · United States
NIA NIH HHS · AG14473 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com